Publications of Juliana Coronel

Coronel, J., Gränicher, G., Sandig, V., Noll, T., Genzel, Y., & Reichl, U. (2020)Application of an Inclined Settler for Cell Culture-Based Influenza A Virus Production in Perfusion ModeFrontiers in Bioengineering and Biotechnology, 8, 672doi: 10.3389/fbioe.2020.00672.

Gränicher, G., Coronel, J., Trampler, F., Jordan, I., Genzel, Y., & Reichl, U. (2020)Performance of an Acoustic Settler Versus a Hollow Fiber-Based ATF Technology for Influenza Virus Production in PerfusionApplied Microbiology and Biotechnology, 104 (11), 4877–4888doi: 10.1007/s00253-020-10596-x.

Coronel, J., Behrendt, I., Bürgin, T., Anderlei, T., Sandig, V., Reichl, U., & Genzel, Y. (2019)Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systemsVaccine, 37 (47), 7011–7018doi: 10.1016/j.vaccine.2019.06.005.

Gränicher, G., Coronel, J., Pralow, A., Marichal-Gallardo, P., Wolff, M. W., Rapp, E., Karlas, A., Sandig, V., Genzel, Y., & Reichl, U. (2019)Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1Vaccine, 37 (47), 7019–7028doi: 10.1016/j.vaccine.2019.04.030.

Bürgin, T., Coronel, J., Hagens, G., Keebler, M. V., Genzel, Y., Reichl, U., & Anderlei, T. (2020)Orbitally Shaken Single-Use Bioreactor for Animal Cell Cultivation: Fed-Batch and Perfusion ModeAnimal Cell Biotechnology105–123New York: Humanadoi: 10.1007/978-1-0716-0191-4_7.

Bürgin, T., Coronel, J., Fiddeke, K., Karlas, A., Sandig, V., Genzel, Y., Reichl, U., & Anderlei, T. (2022)Producing viruses in orbit: Current developments for orbital shaken viral vaccine manufacturingIn: Proceedings Vaccine Technology VIII, 54.

Coronel, J., Genzel, Y., Reichl, U., Behrendt, I., Buergin, T., Andereli, T., & Sandig, V. (2018)Orbital shaken bioreactor for influenza A virus production in high cell density cultivationsIn: Vaccine Technology VII, 40.

Coronel, J., Behrendt, I., Bürgin, T., Anderlei, T., Sandig, V., Genzel, Y., & Reichl, U.Orbital shaken bioreactor for influenza A virus production in high cell density cultivationsPresented at: Vaccine Technology VIIMont Tremblant, Canada, June 17, 2018.